Nuzenio

Biolabs

Biolabs news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - MoomooMoomoo · Fri, 07 Aug 2026 13:00:00 GMTNanjing Leads Biolabs Co., Ltd. Advances Opamtistomig (Pd-L1/4-1Bb Bispecific Antibody) to Expansion Phase in First-Line Hepatocellular Carcinoma Clinical Study - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 10:52:26 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals - mykxlg.commykxlg.com · Thu, 06 Aug 2026 00:53:33 GMTLeads Biolabs Wins IND Approval to Test Opamtistomig in Metastatic Colorectal Cancer - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMTCreative Biolabs Expands Preclinical Pipeline Solutions for Next-Generation CIK and CAR-CIK Cell Therapies - StreetInsiderStreetInsider · Wed, 05 Aug 2026 14:37:37 GMTAfter Taipei, Tokyo and Seoul, 20/20 BioLabs to discuss deal options - Stock TitanStock Titan · Wed, 05 Aug 2026 07:00:00 GMTNew England Biolab® launches Monarch® Mag Cell-free RNA (cfRNA) Extraction Kit to enable total cfRNA isolation from biofluids - PR NewswirePR Newswire · Tue, 04 Aug 2026 14:00:00 GMTChina IND nod for Leads Biolabs’ LBL-024 in colorectal cancer - bioworld.combioworld.com · Mon, 03 Aug 2026 13:00:00 GMT

Timeline

Fri, 07 Aug 2026 13:00:00 GMTVirax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - Moomoo
Thu, 06 Aug 2026 10:52:26 GMTNanjing Leads Biolabs Co., Ltd. Advances Opamtistomig (Pd-L1/4-1Bb Bispecific Antibody) to Expansion Phase in First-Line Hepatocellular Carcinoma Clinical Study - marketscreener.com
Thu, 06 Aug 2026 00:53:33 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals - mykxlg.com
Wed, 05 Aug 2026 19:39:16 GMTLeads Biolabs Wins IND Approval to Test Opamtistomig in Metastatic Colorectal Cancer - BioPharm International
Wed, 05 Aug 2026 14:37:37 GMTCreative Biolabs Expands Preclinical Pipeline Solutions for Next-Generation CIK and CAR-CIK Cell Therapies - StreetInsider
Wed, 05 Aug 2026 07:00:00 GMTAfter Taipei, Tokyo and Seoul, 20/20 BioLabs to discuss deal options - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biolabs.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.